Compare Novavax Inc (NVAX) vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $40.37. Which is the better fit depends on your goals.
| NVAX | QDTY | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $11.19 | $46.71 |
52-Week Low | $6.22 | $36.57 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF
QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →
